Prevention of tumor spread by matrix metalloproteinase-9 inhibition: Old drugs, new concept

European Journal of Internal Medicine

Volumn 13, Issue 2, 2002, Pages 101-103

  Lev, Shaul ^a   Gilburd, Boris ^a   Lahat, Niza ^a   Shoenfeld, Yehuda ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Aspirin; HMG CoA reductase inhibitors; Intravenous gammaglobulins; IVIG; Metalloproteinases; Metastasis

Indexed keywords

ACETYLSALICYLIC ACID; ANTINEOPLASTIC AGENT; BATIMASTAT; CERIVASTATIN; GELATINASE B; GEMCITABINE; IMMUNOGLOBULIN; MATRIX METALLOPROTEINASE INHIBITOR; MEVINOLIN; SIMVASTATIN;

CANCER ADJUVANT THERAPY; DRUG SAFETY; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; METASTASIS; REVIEW;

EID: 0036122586     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0953-6205(02)00011-0     Document Type: Review

References (23)

1. Regulation of matrix metalloproteinase in tumor invasion
2. Experimental and clinical studies on the use of matrix metalloproteinases inhibitors for the treatment of cancer
3. Addition of matrix metalloproteinase inhibition to conventional cytotoxic therapy reduces tumor implantation and prolongs survival in a murine model of human pancreatic cancer
4. Aspirin use and risk of fatal cancer
5. Aspirin and the risk of colorectal cancer in women
6. Effect of anti-inflammatory drugs on overall risk of common cancer: Case-control study in general practice research database
7. (±)-Catechin inhibits intestinal tumor formation and suppresses focal adhesionkinase activation in the Min/+ mouse
8. Inhibition of NF-B by sodium salicylate and aspirin
9. Aspirin inhibits tumor cell invasiveness induced by Epstein-Barr virus latent membrane protein 1 through suppression of matrix metalloproteinase-9 expression
10. Lovastatin inhibits tumor growth and metastasis development of a rat fibrosarcoma
11. Katoh metastasis of B16F10 mouse melanoma inhibited by lovastatin, an inhibitor of cholesterol biosynthesis
12. Follow-up study of patients randomized in the Scandinavian simvastatin survival study (4S) of cholesterol lowering
13. Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and the risk of cancer: A nested case-control study
14. Lovastatin 5-year safety and efficacy study
15. Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trial
16. Inhibition of Ras farnesylation by lovastatin leads to downregulation of proliferation and migration in primary cultured human glioblastoma cells
17. Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase
18. HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages
19. Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits urokinase/urokinase-receptor expression and MMP-9 secretion by peripheral blood monocytes - A possible protective mechanism against atherothrombosis
20. An HMG-CoA reductase inhibitor, Cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro
21. Gamma-globulin inhibits tumor spread in mice
22. Shrinkage of melanoma metastases following high dose intravenous immunoglobulin treatment
23. IVIG inhibits the production of MMP-9 in macrophages